- Home
- ENTA vs AENT Comparison
ENTA vs AENT Comparison
Compare ENTA & AENT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTA
- AENT
- Stock Information
- Founded
- ENTA 1995
- AENT 1990
- Country
- ENTA United States
- AENT United States
- Employees
- ENTA N/A
- AENT N/A
- Industry
- ENTA Biotechnology: Pharmaceutical Preparations
- AENT Durable Goods
- Sector
- ENTA Health Care
- AENT Consumer Discretionary
- Exchange
- ENTA Nasdaq
- AENT Nasdaq
- Market Cap
- ENTA 160.3M
- AENT 161.5M
- IPO Year
- ENTA 2013
- AENT N/A
- Fundamental
- Price
- ENTA $7.89
- AENT $5.35
- Analyst Decision
- ENTA Buy
- AENT Strong Buy
- Analyst Count
- ENTA 4
- AENT 1
- Target Price
- ENTA $18.00
- AENT $10.00
- AVG Volume (30 Days)
- ENTA 181.3K
- AENT 38.2K
- Earning Date
- ENTA 08-04-2025
- AENT 05-15-2025
- Dividend Yield
- ENTA N/A
- AENT N/A
- EPS Growth
- ENTA N/A
- AENT N/A
- EPS
- ENTA N/A
- AENT 0.23
- Revenue
- ENTA $64,462,999.00
- AENT $1,072,641,000.00
- Revenue This Year
- ENTA N/A
- AENT $4.77
- Revenue Next Year
- ENTA $0.48
- AENT N/A
- P/E Ratio
- ENTA N/A
- AENT $23.23
- Revenue Growth
- ENTA N/A
- AENT N/A
- 52 Week Low
- ENTA $4.09
- AENT $1.10
- 52 Week High
- ENTA $17.24
- AENT $11.57
- Technical
- Relative Strength Index (RSI)
- ENTA 67.33
- AENT 82.02
- Support Level
- ENTA $6.95
- AENT $3.70
- Resistance Level
- ENTA $8.23
- AENT $4.33
- Average True Range (ATR)
- ENTA 0.40
- AENT 0.38
- MACD
- ENTA 0.00
- AENT 0.17
- Stochastic Oscillator
- ENTA 75.11
- AENT 100.00
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
About AENT Alliance Entertainment Holding Corporation
Alliance Entertainment Holding Corp is a top-tier distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world.